Results 11 to 20 of about 2,041,725 (223)
Hereditas, 2020 Background Acute mountain sickness has become a heavily researched topic in recent years. However, the genetic mechanism and effects have not been elucidated. Our goal is to construct a gene co-expression network to identify the key modules and hub genes
Yue Chang +6 more
doaj +1 more source
Prediction of acute mountain sickness [PDF]
BMJ, 1995 Acute mountain sickness is a common problem when ascending above 3000 m.1 2 3 Attempts to predict its development have so far been unsuccessful, and the side effects of current prophylaxis limit its widespread use. We tried to develop a simple clinical method of prediction.
AUSTIN, D, SLEIGH, J
openaire +4 more sources
Journal of Education, Health and Sport, 2020 The hypoxia is the main cause of altitude sickness, that usually starts from the benign form - acute mountain sickness (AMS), that being untreated can progress to the life-threatening states, like high altitude pulmonary edema (HAPE) and high altitude ...
Karol Mazur +4 more
doaj +1 more source
Neutrophil gelatinase-associated lipocalin: its response to hypoxia and association with acute mountain sickness. [PDF]
, 2013 Acute Mountain Sickness (AMS) is a common clinical challenge at high altitude (HA). A point-of-care biochemical marker for AMS could have widespread utility.
O'Hara, J +11 more
core +1 more source
High Altitude Medicine & Biology, 2002 AFIT 57-YEAR-OLD MALE trekker/climber presented at Dingboche, Nepal (4420 m), with severely limited exercise tolerance (it was an effort for him to walk from his room to the dining area), headache, and nausea. These symptoms first appeared 2 days earlier when he returned to Lobouche (5029 m) after climbing Kalapatar (5600 m).
Taylor, A +10 more
openaire +3 more sources
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort
Communications Biology, 2022 Potential acute mountain sickness diagnostic, predictive, protective biomarkers are established using plasma proteomic, clinical and symptom phenotype data with machine learning approaches in a longitudinal cohort of 53 individuals.
Jing Yang +6 more
doaj +1 more source
Effects of age on hypoxic tolerance in women
Current Issues in Sport Science, 2023 Introduction The prevalence of acute mountain sickness (AMS) is increasing with altitude (i.e., 10-25% at 2,500 m and 50-85% at ~ 5,000 m; Bärtsch & Swenson, 2013). While there is no error-free test to predict its occurrence, several risk factors and
Tom Citherlet +3 more
doaj +1 more source
Prevention and treatment of high altitude cerebral edema (HACE)
Journal of Education, Health and Sport, 2020 High altitude cerebral edema (HACE) is often a severe and potentially fatal manifestation of acute mountain sickness (AMS). It usually develops within the first 2 in individuals rapidly ascending at altitudes above 4000 m.
Karol Mazur +4 more
doaj +1 more source
High-altitude illness: Management approach
Turkish Journal of Emergency Medicine, 2019 In high altitudes, usually above 2500 m, travelers are faced with decreased partial pressure of oxygen along with decreased barometric pressure. High-altitude illness, a syndrome of acute mountain sickness, high-altitude cerebral edema and high-altitude ...
Gökhan Aksel +2 more
doaj +1 more source
Acute mountain sickness amongst tourists to Lhasa [PDF]
, 2017 Acute mountain sickness is the commonest acute high altitude illness occurring at high altitude. Its prevalence is dependent on the ascent rate, altitude achieved, physical effort required to reach the target altitude and pharmacological intervention ...
Bhattachar, Srinivasa +3 more
core +1 more source